Arcturus Therapeutics Holdings Management
How experienced are the management team and are they aligned to shareholders interests?
4.3yrs
Average management tenure
CEO
Joe Payne (50 yo)
9.83yrs
Tenure
US$960,000
Compensation
Mr. Joseph E. Payne, also known as Joe, M.Sc., has been Independent Non-Executive Director of Vallon Pharmaceuticals, Inc. since June 22, 2018. Mr. Payne has been Director of Arcturus since November 2017....
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$147m |
| Jun 30 2022 | n/a | n/a | -US$165m |
| Mar 31 2022 | n/a | n/a | -US$198m |
| Dec 31 2021 | US$960k | US$600k | -US$204m |
| Sep 30 2021 | n/a | n/a | -US$196m |
| Jun 30 2021 | n/a | n/a | -US$163m |
| Mar 31 2021 | n/a | n/a | -US$119m |
| Dec 31 2020 | US$13m | US$500k | -US$72m |
| Sep 30 2020 | n/a | n/a | -US$52m |
| Jun 30 2020 | n/a | n/a | -US$38m |
| Mar 31 2020 | n/a | n/a | -US$29m |
| Dec 31 2019 | US$1m | US$450k | -US$26m |
| Sep 30 2019 | n/a | n/a | -US$16m |
| Jun 30 2019 | n/a | n/a | -US$13m |
| Mar 31 2019 | n/a | n/a | -US$22m |
| Dec 31 2018 | US$3m | US$425k | -US$22m |
| Sep 30 2018 | n/a | n/a | -US$26m |
| Jun 30 2018 | n/a | n/a | -US$25m |
| Mar 31 2018 | n/a | n/a | -US$16m |
| Dec 31 2017 | US$449k | US$384k | -US$11m |
Compensation vs Market: Joe's total compensation ($USD960.00K) is below average for companies of similar size in the US market ($USD2.52M).
Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.83yrs | US$960.00k | 5.57% $ 29.4m | |
| Founder | 10yrs | US$750.00k | 2.24% $ 11.8m | |
| CFO & Director | 4.42yrs | US$750.00k | 1.01% $ 5.4m | |
| Chief Legal Officer | 2.42yrs | US$560.00k | no data | |
| Strategic Clinical Advisor & Member of Scientific Advisory Board | 3yrs | US$644.00k | no data | |
| VP of Finance & Corporate Controller | 4.33yrs | no data | no data | |
| Executive VP & Chief Technology Officer | no data | no data | no data | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Senior Analyst of Investor & Public Relations | no data | no data | no data | |
| Chief Business Officer | 4.33yrs | no data | no data | |
| Chief Development Officer | 1yr | no data | no data |
4.3yrs
Average Tenure
52yo
Average Age
Experienced Management: ARCT's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.83yrs | US$960.00k | 5.57% $ 29.4m | |
| CFO & Director | 3.33yrs | US$750.00k | 1.01% $ 5.4m | |
| Strategic Clinical Advisor & Member of Scientific Advisory Board | 0.83yr | US$644.00k | no data | |
| Independent Chairman of the Board | 4.67yrs | US$389.78k | 0.36% $ 1.9m | |
| Independent Director | 3.33yrs | US$377.28k | no data | |
| Independent Director | 4.67yrs | US$387.28k | 0.038% $ 198.8k | |
| Independent Director | 4.67yrs | US$377.28k | 0.086% $ 451.7k | |
| Member of the Vaccine Platform Scientific Advisory Board | 2.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 8.08yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.17yrs | no data | no data | |
| Member of the Vaccine Platform Scientific Advisory Board | 2.5yrs | no data | no data | |
| Member of the Vaccine Platform Scientific Advisory Board | 2.5yrs | no data | no data |
4.0yrs
Average Tenure
63yo
Average Age
Experienced Board: ARCT's board of directors are considered experienced (4 years average tenure).